How the FDA Monitors Generic Drug Safety After Approval
The FDA doesn't stop monitoring generic drugs after approval. It uses millions of reports, sales data, and advanced tools to catch manufacturing flaws and safety issues. But gaps remain - especially for drugs where small changes can affect how well they work.